65 years of clinical trials in the eradication of tuberculosis
Symposium is being held in recognition of 65 years of research carried out by Professor Denny Mitchison on the occasion of his 90th birthday
Meeting to be held on Friday 18th September 2009 from 8.30 am – 5 pm
REGISTRATION: | 08h30 – 09h00 | |
First morning session: | ||
Welcome and introductions: Clinical trials in tuberculosis past, present and future | Chair: Professor George Griffin | 09h00 – 09h15 |
The first trial | Professor Denny Mitchison | 09h15 – 09h30 |
The subsequent trials | Professor Janet Darbyshire | 09h30 – 9h50 |
The future trials | Dr. Gerry Davies | 9h50 – 10h10 |
Coffee break followed by Second morning session: | 10h10-10h30 | |
Second morning session: Chemotherapy in tuberculosis | Chair : Professor Anthony Coates | |
Role of chemotherapy in tuberculosis control | Dr. Christopher Dye | 10h30–10h50 |
Genomic targets | Professor Philip Butcher | 10h50–11h05 |
Alternative choices for targets | Professor Anthony Coates | 11h05–11h20 |
Challenges in TB drug development | Dr. Ann Ginsberg | 11h20–11h40 |
Discussion | 11h40-12h10 | |
Concepts in chemotherapy | Professor Denny Mitchison | 12h10–12h40 |
Nanotechnology in chemotherapy | Dr. Bernard Fourie | 12h40–13h00 |
Discussion | 13h00–13h15 | |
LUNCH | 13h15-14h15 | |
Afternoon session: Risks and benefits associated with clinical trials | Chair: Professor Peter Kopelman | |
Statistical risks | Professor Andrew Nunn | 14h15–14h35 |
Regulatory procedures | Dr.Amina Jindani | 14h35–14h55 |
Discussion | 14.55 – 16.15 | |
Conclusions for the future | Professor George Griffin | 16h15–16h25 |
Discussion | 16h30–17h00 | |
Farewell tea | 17h00 |